{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Fluarix&page=24", "query": { "intervention": "Fluarix", "page": 24 }, "page_size": 10 }, "pagination": { "page": 24, "page_size": 10, "total_count": 1159, "total_pages": 116, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Fluarix&page=25&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Fluarix&page=23&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-20T12:44:33.534Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00610935", "title": "Intramuscular Peramivir in Subjects With Uncomplicated Acute Influenza", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Influenza" ], "interventions": [ { "name": "Peramivir", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "BioCryst Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 82, "start_date": "2008-01", "completion_date": "2008-02", "has_results": true, "last_update_posted_date": "2021-03-17", "last_synced_at": "2026-10-20T12:44:33.534Z", "location_count": 96, "location_summary": "Millbrook, Alabama • Tuscaloosa, Alabama • Phoenix, Arizona + 80 more", "locations": [ { "city": "Millbrook", "state": "Alabama" }, { "city": "Tuscaloosa", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Jonesboro", "state": "Arkansas" }, { "city": "Jonesboro", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00610935" }, { "nct_id": "NCT01443663", "title": "Evaluating the Safety and Immune Response to an H5N1 Influenza Vaccine in People Who Have Previously Received an H5N1 or H7N3 Influenza Vaccine and in People Who Have Never Received a Live Attenuated Influenza Vaccine", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "H5N1 Influenza" ], "interventions": [ { "name": "H5N1 Vaccine", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": true, "eligibility": { "minimum_age": "22 Years", "maximum_age": "54 Years", "sex": "ALL", "summary": "22 Years to 54 Years" }, "enrollment_count": 69, "start_date": "2011-10", "completion_date": "2013-03", "has_results": false, "last_update_posted_date": "2016-02-09", "last_synced_at": "2026-10-20T12:44:33.534Z", "location_count": 1, "location_summary": "Baltimore, Maryland", "locations": [ { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT01443663" }, { "nct_id": "NCT07204964", "title": "A Study to Evaluate the Immune Response and Safety of an Influenza Vaccine in Adults 18 Years of Age and Above", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Influenza, Human" ], "interventions": [ { "name": "Flu mRNA (Formulation B1)", "type": "BIOLOGICAL" }, { "name": "Flu mRNA (Formulation B3)", "type": "BIOLOGICAL" }, { "name": "Flu mRNA(Formulation A)", "type": "BIOLOGICAL" }, { "name": "Comparator 1", "type": "COMBINATION_PRODUCT" }, { "name": "Comparator 2", "type": "COMBINATION_PRODUCT" }, { "name": "Comparator 3", "type": "COMBINATION_PRODUCT" } ], "intervention_types": [ "BIOLOGICAL", "COMBINATION_PRODUCT" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 971, "start_date": "2025-10-07", "completion_date": "2026-08-24", "has_results": false, "last_update_posted_date": "2026-09-18", "last_synced_at": "2026-10-20T12:44:33.534Z", "location_count": 15, "location_summary": "Guntersville, Alabama • Canoga Park, California • Walnut Creek, California + 12 more", "locations": [ { "city": "Guntersville", "state": "Alabama" }, { "city": "Canoga Park", "state": "California" }, { "city": "Walnut Creek", "state": "California" }, { "city": "Hialeah", "state": "Florida" }, { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT07204964" }, { "nct_id": "NCT05395052", "title": "FT536 Monotherapy and in Combination With Monoclonal Antibodies in Advanced Solid Tumors", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Non Small Cell Lung Cancer", "Colorectal Cancer", "Breast Cancer", "Ovarian Cancer", "Pancreatic Cancer", "Head and Neck Cancer", "GastroEsophageal Cancer" ], "interventions": [ { "name": "FT536", "type": "DRUG" }, { "name": "Cyclophosphamide", "type": "DRUG" }, { "name": "Fludarabine", "type": "DRUG" }, { "name": "IL-2", "type": "DRUG" }, { "name": "Avelumab", "type": "COMBINATION_PRODUCT" }, { "name": "Pembrolizumab", "type": "COMBINATION_PRODUCT" }, { "name": "Nivolumab", "type": "COMBINATION_PRODUCT" }, { "name": "Atezolizumab", "type": "COMBINATION_PRODUCT" }, { "name": "Trastuzumab", "type": "COMBINATION_PRODUCT" }, { "name": "Cetuximab", "type": "COMBINATION_PRODUCT" }, { "name": "Amivantamab", "type": "COMBINATION_PRODUCT" } ], "intervention_types": [ "DRUG", "COMBINATION_PRODUCT" ], "sponsor": "Fate Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 5, "start_date": "2022-05-31", "completion_date": "2023-08-11", "has_results": false, "last_update_posted_date": "2023-09-21", "last_synced_at": "2026-10-20T12:44:33.534Z", "location_count": 5, "location_summary": "Scottsdale, Arizona • Los Angeles, California • Hackensack, New Jersey + 2 more", "locations": [ { "city": "Scottsdale", "state": "Arizona" }, { "city": "Los Angeles", "state": "California" }, { "city": "Hackensack", "state": "New Jersey" }, { "city": "Huntersville", "state": "North Carolina" }, { "city": "San Antonio", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT05395052" }, { "nct_id": "NCT01967238", "title": "An Open Label Study of IgG Fc Glycan Composition in Human Immunity", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "IM Pneumococcal, meningococcal, or flu vaccine", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Rockefeller University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 129, "start_date": "2013-03", "completion_date": "2023-03", "has_results": true, "last_update_posted_date": "2024-09-19", "last_synced_at": "2026-10-20T12:44:33.534Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT01967238" }, { "nct_id": "NCT01375985", "title": "Safety Study of Single Administration Intravenous Treatment for Influenza", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Influenza" ], "interventions": [ { "name": "AVI-7100", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sarepta Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "50 Years", "sex": "ALL", "summary": "18 Years to 50 Years" }, "enrollment_count": 8, "start_date": "2011-06", "completion_date": "2011-11", "has_results": false, "last_update_posted_date": "2013-06-11", "last_synced_at": "2026-10-20T12:44:33.534Z", "location_count": 1, "location_summary": "Madison, Wisconsin", "locations": [ { "city": "Madison", "state": "Wisconsin" } ], "official_url": "https://clinicaltrials.gov/study/NCT01375985" }, { "nct_id": "NCT00192335", "title": "Trial to Demonstrate Equivalent Immunogenicity of CAIV-T and FLUMIST in Healthy Participants", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "CAIV-T", "type": "BIOLOGICAL" }, { "name": "CAIVT", "type": "BIOLOGICAL" }, { "name": "FluMist", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "MedImmune LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "5 Years", "maximum_age": "49 Years", "sex": "ALL", "summary": "5 Years to 49 Years" }, "enrollment_count": 890, "start_date": "2004-07", "completion_date": "2005-02", "has_results": false, "last_update_posted_date": "2007-11-27", "last_synced_at": "2026-10-20T12:44:33.534Z", "location_count": 3, "location_summary": "Shawnee Mission, Kansas • Bardstown, Kentucky • Lake Jackson, Texas", "locations": [ { "city": "Shawnee Mission", "state": "Kansas" }, { "city": "Bardstown", "state": "Kentucky" }, { "city": "Lake Jackson", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00192335" }, { "nct_id": "NCT05799976", "title": "Text Message-Based Nudges Prior to Primary Care Visits to Increase Care Gap Closure", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Pneumonia, Pneumococcal", "Diabetes Mellitus", "Breast Cancer", "Colorectal Cancer" ], "interventions": [ { "name": "Text message nudge", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Mitesh Patel", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 29334, "start_date": "2023-09-05", "completion_date": "2024-02-09", "has_results": false, "last_update_posted_date": "2024-04-25", "last_synced_at": "2026-10-20T12:44:33.534Z", "location_count": 1, "location_summary": "St Louis, Missouri", "locations": [ { "city": "St Louis", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT05799976" }, { "nct_id": "NCT05705440", "title": "A Follow-up Study to Describe the Safety of Study Participants Who Received RSVPreF3 Maternal Vaccination (Any Dose) or Controls From Previous RSV MAT Studies During Any Pregnancy Conceived Post Vaccination/Control", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Respiratory Syncytial Virus Infections" ], "interventions": [ { "name": "RSVPreF3 vaccine", "type": "BIOLOGICAL" }, { "name": "Control", "type": "OTHER" } ], "intervention_types": [ "BIOLOGICAL", "OTHER" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "9 Years", "maximum_age": "49 Years", "sex": "FEMALE", "summary": "9 Years to 49 Years · Female only" }, "enrollment_count": 3855, "start_date": "2023-02-07", "completion_date": "2025-01-15", "has_results": true, "last_update_posted_date": "2026-03-17", "last_synced_at": "2026-10-20T12:44:33.534Z", "location_count": 27, "location_summary": "Mobile, Alabama • Phoenix, Arizona • Tucson, Arizona + 21 more", "locations": [ { "city": "Mobile", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Burbank", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05705440" }, { "nct_id": "NCT00664417", "title": "Study of Different Formulations of an Intramuscular A/H5N1 Inactivated, Split Virion Influenza Adjuvanted Vaccine", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Influenza", "Orthomyxoviridae Infections" ], "interventions": [ { "name": "Monovalent subvirion H5N1 influenza vaccine", "type": "BIOLOGICAL" }, { "name": "Physiological saline", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Sanofi", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "40 Years", "sex": "ALL", "summary": "18 Years to 40 Years" }, "enrollment_count": 375, "start_date": "2008-04", "completion_date": "2010-08", "has_results": false, "last_update_posted_date": "2012-04-17", "last_synced_at": "2026-10-20T12:44:33.534Z", "location_count": 6, "location_summary": "San Diego, California • South Miami, Florida • Springfield, Missouri + 2 more", "locations": [ { "city": "San Diego", "state": "California" }, { "city": "South Miami", "state": "Florida" }, { "city": "Springfield", "state": "Missouri" }, { "city": "Cincinnati", "state": "Ohio" }, { "city": "Cincinnati", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT00664417" } ] }